Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.10    0.00 (0.00%)
Bid:
1.00
Ask:
1.20
Spread: 0.20 (20.00%)
Market Cap: £9.41m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Result of AGM

27 Jun 2024 12:00

RNS Number : 1855U
Tern PLC
27 June 2024
 

27 June 2024

 

Tern Plc

 

("Tern" or the "Company")

Result of AGM

Tern Plc (AIM:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things ("IoT") technology businesses, announces that at the Company's Annual General Meeting ("AGM") held earlier today resolutions 1, 2, 3, 4 and 6 were passed on a poll. Resolution 5 was not passed.

 

Following resolution 5 not being passed, the Directors do not currently have the authority to issue new ordinary shares disapplying statutory pre-emption rights. As stated in the Company's Notice of 2024 Annual General Meeting (the "Notice"), dated 30 May 2024, should the Share Issuance Resolutions not be passed the Company will likely be required to seek to satisfy its further funding requirements from the disposal of holdings in its portfolio in the short-term and in a timeframe and potentially in a manner that may not be in the best interests of the Company and its shareholders. In these circumstances the Directors believe that the Company may also suffer greater dilution of its remaining portfolio holdings than if the Company was able to drawdown further on the Facility or had access to potential funding through the issue of Ordinary Shares. The Directors believe that today's failure to pass the Share Issuance Resolutions may likely therefore result in a lower value being ultimately achieved for the Company's shareholders.

 

Whilst Resolutions 3 and 4 were passed with the necessary majority, the Board also notes the voting in relation to these resolutions. The Board is committed to continuing an open dialogue with the Company's shareholders. Following the voting at the AGM, where it is able to, the Board will continue to seek to engage with those shareholders who are understood to have voted against certain of the resolutions to understand their views and/or any specific concerns, including the votes received against resolution 5 representing approximately 7.7 per cent. of the Company's issued share capital.

 

Details of the poll voting on each resolution are set out below:

 

Resolution

Votes For*

Votes Against

Votes Withheld**

Total Votes Cast (excluding Withheld)**

No. of ordinary shares

% of ordinary shares voted**

No. of ordinary shares

% of ordinary shares voted**

No. of ordinary shares

 

ORDINARY RESOLUTIONS

1. To receive and adopt the accounts for the financial year ended 31 December 2023

92,223,142

 

90.6%

 

9,588,214

 

9.4%

 

3,356,330

 

101,811,356

 

2. To re-appoint Evelyn Partners as auditors of the Company and to authorise the Directors to determine their remuneration.

93,367,227

 

91.6%

 

8,567,837

 

8.4%

 

3,232,622

 

101,935,064

 

3. To re-appoint Ian Ritchie as a Director of the Company

65,305,925

 

63.2%

 

37,960,708

 

36.8%

 

1,901,053

 

103,266,633

 

4. To authorise the Directors to allot securities

72,030,870

 

68.7%

 

32,769,708

 

31.3%

 

367,108

 

104,800,578

 

 

SPECIAL RESOLUTIONS

5. To disapply statutory pre-emption rights

72,022,360

 

68.5%

 

33,119,708

 

31.5%

 

25,618

 

105,142,068

 

6. To allow the Company to make market purchases of its Ordinary Shares

92,821,946

 

88.3%

 

12,334,213

 

11.7%

 

11,527

 

105,156,159

 

 

* Votes 'For' include votes giving the Chairman discretion.

** A 'Vote Withheld' is not a vote in law and has not been counted in the calculation of the proportion of the votes 'For' and 'Against' a resolution.

 

The resolutions are set out in full in the Notice available on the Company's website at https://ternplc.com/aim-rule-26/ The votes received represented approximately 23.5 to 24.3 per cent. of the Company's issued share capital.

 

Any capitalised terms not otherwise defined in this announcement have the same meaning ascribed to them in the Notice.

 

Enquiries

 

Tern Plc

Ian Ritchie (Chairman)

via IFC Advisory

 

Allenby Capital Limited

(Nominated Adviser and Broker)

Alex Brearley / Dan Dearden-Williams (Corporate Finance)

Kelly Gardiner / Guy McDougall (Sales and Corporate Broking)

 

Tel: 0203 328 5656

 

IFC Advisory

(Financial PR and IR)

Tim Metcalfe

Graham Herring

Florence Chandler

 

Tel: 0203 934 6630

tern@investor-focus.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUBSRRSNUNUAR
Date   Source Headline
23rd Jun 20267:00 amRNSResults for the year ended 31 December 2025
8th Jun 20267:00 amRNSNotice of AGM
29th May 20265:00 pmRNSTotal Voting Rights
26th May 20267:00 amRNSInvestment in Talking Medicines CLNs
22nd May 20267:00 amRNSDevice Authority Convertible Loan Notes Investment
19th May 20267:00 amRNSPlacing to raise £222,000
12th May 20267:00 amRNS-RDevice Authority Strategic Partnership
8th May 202612:53 pmRNSResult of GM & Update on Open Offer
8th May 20267:00 amRNSResults of Open Offer
21st Apr 20267:00 amRNSOpen Offer and Notice of General Meeting
31st Mar 20265:00 pmRNSTotal Voting Rights
5th Mar 20267:00 amRNSExtension of loan facility agreement
3rd Mar 20267:00 amRNSResults of Open Offer
13th Feb 20267:00 amRNSOpen Offer at 0.40p to raise up to £384,408
5th Feb 20267:00 amRNS-RTern Notes Automotive Momentum at Device Authority
15th Jan 20267:00 amRNSUpdate regarding SVV2
8th Jan 20267:00 amRNSInvestor Presentations
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
23rd Dec 20257:00 amRNS-ROnline Investor Presentation and Q&A Session
12th Dec 20257:00 amRNSIssue of Talking Medicines Convertible Loan Notes
28th Nov 20257:00 amRNSUpdate regarding capital commitment to SVV2
25th Nov 20257:00 amRNSTalking Medicines CLN Modifications
31st Oct 20253:35 pmRNSTotal Voting Rights
15th Oct 20257:00 amRNSResults of Open Offer
9th Oct 20257:00 amRNSRemuneration Reductions & Distribution Commitment
29th Sep 20257:00 amRNSOpen Offer to raise up to £642,486
15th Sep 20257:00 amRNSExtension of Loan Facility Term
4th Sep 20257:00 amRNSInterim results for the six months to 30 June 2025
1st Sep 20257:00 amRNSAppointment of shareholder relations adviser
31st Jul 20254:34 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSResults of underwritten Open Offer & TVR
24th Jul 20257:00 amRNSReceipt of Bridging Loan
14th Jul 20257:00 amRNSUnderwritten Open Offer to raise £642,486
30th Jun 202512:07 pmRNSResult of AGM
13th Jun 20257:00 amRNSDirector Share Purchase
11th Jun 20257:00 amRNSDirector Share Purchase
6th Jun 20257:00 amRNSNotice of AGM and Director Retirement
5th Jun 20257:00 amRNSResults for the year ended 31 December 2024
30th May 20255:39 pmRNSTotal Voting Rights
7th May 20257:00 amRNSResults of Underwritten Open Offer
24th Apr 20257:00 amRNSPurple Transform appointment
17th Apr 20257:00 amRNSUnderwritten Open Offer to raise £340,140
11th Mar 20257:00 amRNS-RDevice Authority Microsoft & CyberArk Partnership
11th Mar 20257:00 amRNS-RSure Ventures Update
28th Feb 20255:00 pmRNSTotal Voting Rights
21st Feb 20257:00 amRNSPlacing to raise £221,154
14th Jan 20257:30 amRNS-RProgressive Equity Research Report
10th Jan 20257:00 amRNSInvestor Presentations
2nd Jan 20257:00 amRNSInvestment in Sure Ventures plc
31st Dec 20241:30 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.